Sano blog (28)

public health genetic testing population health

Genetic screening for prevention: Benefits and barriers

Many hereditary diseases are clinically manageable when detected early, yet most carriers are identified only after symptoms appear. Population genomic screenin...

patient recruitment neurodegenerative disease patient engagement

Webinar recap: Parkinson's disease engagement, screening, and retention

In this webinar, “Parkinson's disease: Engagement, screening, and retention," Sano CEO and Co-Founder Patrick Short shares a case study of Sano’s work on a gene...

precision medicine genetic testing

How genetics is redefining precision healthcare

Precision medicine represents a fundamental shift in how treatments are developed and delivered. Rather than relying on population-level assumptions about how p...

public health rare disease health equity

Newborn screening equity: Sequencing and global gaps

Over the last two decades, following the landmark achievement of sequencing the first complete human genome, a suite of powerful genetic tools has emerged. Gene...

precision medicine thought leadership

Regenerative medicine & tissue engineering in modern healthcare

Tissue engineering and regenerative medicine (TERM), integral to the evolution of precision medicine, are advancing methods to regenerate or repair damaged tiss...

biomarkers genetic testing

Webinar recap: Genetic essentials for clinical research professionals, Part 2

Last year, Sano CEO Dr. Patrick Short presented a webinar called “Genetics Essentials for Clinical Research professionals.” In it, he explained the fundamentals...

data privacy public health genetic testing

Prenatal genetic testing: NIPT, ethics, and newborn care

Genomic screening is changing how clinicians and families approach prenatal and neonatal care. These tests, which analyze fetal or newborn DNA for chromosomal c...

thought leadership public health genetic testing

Newborn genome sequencing: Clinical and ethical perspectives

In a webinar hosted by Dr. Patrick Short, CEO of Sano Genetics, and featuring Dr. Wendy Chung, Dr. Holly Peay, and Kira Dineen, panelists explored recent develo...

biomarkers genetic epidemiology genetic testing

Long COVID: How immunogenetics shapes immune response

The global focus around COVID-19 has shifted from acute infections to the lingering challenge posed by long COVID, a condition where signs and symptoms persist ...